|
Ontuxizumab is a monoclonal antibody designed for the treatment of cancer.〔(Statement On A Nonproprietary Name Adopted By The USAN Council - Evolocumab ), ''American Medical Association''.〕 It binds to TEM1. This drug was developed by Morphotek, Inc. == References == 〔 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Ontuxizumab」の詳細全文を読む スポンサード リンク
|